52 results
Page 2 of 3
6-K
EX-99.2
z7760vd49m
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
n784g3asg7
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.3
6mljlpu
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
cg0o61h3ivwk9d
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
vbc4jms
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
ousbx8sjm4z9auk di
19 Feb 21
Pipeline and capital for growth
6:00am
6-K
EX-99.2
jes606jm4pdrwijdcm6
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.2
nxcc3bal
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.2
zlp1w0
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.2
lmdoou5ewo1o09c j2
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.2
u5792vfwkwtkyat4s
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.3
8vt3zci hvg4n8
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99
dmteldxo
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99.2
tep46s x5ny
26 Apr 19
Galapagos reports on historic first quarter 2019
4:06pm
F-3ASR
82qvyh3k
29 Mar 19
Automatic shelf registration (foreign)
5:26pm
6-K
EX-99.2
3uus5fcabpewjyp
26 Oct 18
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
4:19pm
424B5
1tz6t2
13 Sep 18
Prospectus supplement for primary offering
12:00am